Xponance, Inc. Repligen Corp Transaction History

Xponance, Inc.

$11.7 Billion
Q2 2025

A detailed history of Xponance, Inc. transactions in Repligen Corp stock. As of the latest transaction made, Xponance, Inc. holds 6,563 shares of RGEN stock, worth $1.03 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

6,563

Previous 6,989 6.1%

Holding current value

$1.03 Million

Previous $889,000 8.21%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$108.89 - $145.23 $46,387 - $61,867	-426 Reduced 6.1%	6,563 $816,000
Q1 2025 Apr 30, 2025	BUY	$127.24 - $174.24 $6,362 - $8,712	50 Added 0.72%	6,989 $889,000
Q4 2024 Feb 10, 2025	BUY	$123.41 - $160.92 $56,645 - $73,862	459 Added 7.08%	6,939 $998,000
Q3 2024 Nov 12, 2024	SELL	$119.79 - $167.35 $302,469 - $422,558	-2,525 Reduced 28.04%	6,480 $964,000
Q2 2024 Aug 14, 2024	SELL	$120.0 - $182.95 $254,760 - $388,402	-2,123 Reduced 19.08%	9,005 $1.14 Million
Q1 2024 May 13, 2024	BUY	$170.78 - $208.42 $380,668 - $464,568	2,229 Added 25.05%	11,128 $2.05 Million
Q4 2023 Jan 31, 2024	SELL	$114.17 - $185.35 $7,192 - $11,677	-63 Reduced 0.7%	8,899 $1.6 Million
Q3 2023 Oct 23, 2023	SELL	$138.78 - $176.51 $9,714 - $12,355	-70 Reduced 0.78%	8,962 $1.43 Million
Q2 2023 Jul 13, 2023	SELL	$138.42 - $180.31 $263,966 - $343,851	-1,907 Reduced 17.43%	9,032 $1.28 Million
Q1 2023 Apr 17, 2023	SELL	$154.26 - $198.1 $10,181 - $13,074	-66 Reduced 0.6%	10,939 $1.84 Million
Q4 2022 Jan 23, 2023	BUY	$162.42 - $220.56 $137,244 - $186,373	845 Added 8.32%	11,005 $0
Q3 2022 Oct 24, 2022	SELL	$160.42 - $256.21 $320 - $512	-2 Reduced 0.02%	10,160 $1.9 Million
Q2 2022 Aug 02, 2022	SELL	$140.68 - $188.02 $119,296 - $159,440	-848 Reduced 7.7%	10,162 $1.65 Million
Q1 2022 Apr 20, 2022	SELL	$161.19 - $257.96 $20,793 - $33,276	-129 Reduced 1.16%	11,010 $2.07 Million
Q4 2021 Jan 31, 2022	BUY	$247.59 - $304.47 $2,971 - $3,653	12 Added 0.11%	11,139 $2.95 Million
Q3 2021 Nov 05, 2021	SELL	$194.77 - $324.21 $83,166 - $138,437	-427 Reduced 3.7%	11,127 $3.22 Million
Q2 2021 Aug 12, 2021	BUY	$165.87 - $220.95 $35,827 - $47,725	216 Added 1.91%	11,554 $2.31 Million
Q1 2021 May 10, 2021	BUY	$180.37 - $226.26 $57,898 - $72,629	321 Added 2.91%	11,338 $2.2 Million
Q4 2020 Feb 11, 2021	BUY	$148.08 - $206.57 $8,292 - $11,567	56 Added 0.51%	11,017 $2.11 Million
Q3 2020 Oct 26, 2020	BUY	$122.51 - $158.27 $155,220 - $200,528	1,267 Added 13.07%	10,961 $1.62 Million
Q2 2020 Aug 14, 2020	BUY	$94.33 - $140.48 $914,435 - $1.36 Million	9,694 New	9,694 $1.2 Million

Others Institutions Holding RGEN

# of Institutions

509

Shares Held

58.9M

Call Options Held

89.3K

Put Options Held

679K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.7B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.

Account